On April 23, 2025, the signing ceremony for the Letter of Intent on Scientific Research Collaboration and Technology Transfer between Peking Union Medical College Hospital (PUMCH) and Shurui Robotics Innovation Demonstration Center was held in Beijing. Building on five years of productive collaboration and significant achievements between PUMCH’s Department of Obstetrics and Gynecology and Shurui Robotics, the two parties will now deepen their partnership to advance research and development of single-port laparoscopic surgical robots, promote the translation of medical innovations, cultivate key clinical and technical personnel, and strengthen international academic exchanges. This comprehensive collaboration aims to leverage China’s original technological breakthroughs to further benefit global healthcare.

In his address, Professor Peng Bin, Vice President of Peking Union Medical College Hospital (PUMCH), emphasized the hospital’s unwavering commitment to scientific and technological innovation as the core driver of its high-quality development. He noted that PUMCH and Shurui have already achieved encouraging milestones, including the successful clinical implementation of gynecological single-port surgical robot technology. Looking ahead, he expressed hope for further deepening collaboration between the two parties to advance joint research and clinical translation projects, pioneer cutting-edge innovations in intelligent minimally invasive surgery, and establish a world-class platform for technological breakthroughs in global healthcare.

The Shurui Single-Port Laparoscopic Surgical Robot, developed through nearly two decades of dedicated research and refinement, employs internationally pioneering and independently patented innovative technologies. It demonstrates technical advantages including extensive range of motion, high load capacity, and exceptional reliability. In 2020, Dr. Sun Dawei, Director of the General Gynecology Center, conducted the first gynecological animal surgery trials using Shurui's experimental prototype in Shanghai. In April 2022, Peking Union Medical College Hospital successfully performed China's first gynecological registration clinical surgery with the Shurui Snake-shaped Arm Single-Port Robot. By 2023, the prospective multi-center registration clinical trials led by the Obstetrics and Gynecology Department of PUMCH had been fully completed. In February 2024, the Shurui Single-Port Robot received medical device registration approval changes from China's National Medical Products Administration (NMPA), authorizing its application in gynecological laparoscopic procedures. Collaborative achievements between the parties were showcased at the 2022 China International Fair for Trade in Services (CIFTIS) and recognized as one of "China's 2023 Notable Medical Advances." This groundbreaking innovation was featured in a special report by CCTV's flagship program Focus Interview.

"Physicians have tangibly recognized the advantages of this new technology in clinical practice, achieving enhanced precision in operations, minimized surgical trauma, and accelerated patient recovery," stated Dr. Sun Dawei. He emphasized their commitment to advancing practical collaboration, promoting the standardized "PUMCH experience" in single-port robotic laparoscopic surgery, exploring broader clinical applications for the technology, and driving innovations such as transvaginal single-port robotic surgery. Additionally, efforts will focus on developing remote surgical capabilities, establishing clinical guidelines and standards, and guiding evidence-based practices. Under the agreement, the two parties will jointly establish the Peking Union Medical College Hospital-Shurui Robotics International Training Center. This platform will provide domestic and international demonstrations of new technology applications and standardized training programs, accelerating the adoption of innovative techniques. The collaboration aims to create a model system for the research, production, and clinical implementation of domestically developed surgical robots, fostering widespread application of cutting-edge medical technologies.

Mr. Xu Kai, Chairman of Beijing Shurui Robotics Co., Ltd., expressed that entering a comprehensive strategic collaboration with Peking Union Medical College Hospital (PUMCH) is both an honor and a responsibility. "By integrating our respective strengths, we will further advance innovation in industry-medicine integration and contribute to the progress of China’s healthcare sector," he stated. Shurui will collaborate closely with PUMCH’s expert teams, positioning physicians as the "core of the chain" and the enterprise as the "central hub", focusing on unmet clinical needs. Through innovation, the partnership aims to pioneer new frontiers, supporting national strategies for scientific advancement and Healthy China initiatives. The signing ceremony was presided over by Director Zhu Lan of PUMCH’s Department of Obstetrics and Gynecology. Representatives from key departments—including Anesthesiology, Operating Room, Research Office, International Cooperation Office, Publicity Department, Planning and Development Office, and Medical Affairs Office—attended the event. Following the signing, both parties held an exchange discussion on the future development of surgical robotics technology and the protection of intellectual property rights, reinforcing their commitment to collaborative innovation and knowledge sharing.